Sort
15,273 grants matching “antimicrobial resistance”
Development of Novel Ophthalmic Antibiotics
$203,404Rachel A F Wozniak · University Of Rochester · K08 · FY2021 · EY
Development of Novel Ophthalmic Antibiotics
$203,404Rachel A F Wozniak · University Of Rochester · K08 · FY2020 · EY
Development of Novel Ophthalmic Antibiotics
$203,404Rachel A F Wozniak · University Of Rochester · K08 · FY2018 · EY
Modifiable Risk Factors for the Emergence of Resistance to Pseudomonas aeruginosa
$203,381Pranita Tamma · Johns Hopkins University · R21 · FY2022 · AI
Quantifying the Race for the Surface via IV-MLSM
$203,280Edward M Schwarz · University Of Rochester · R21 · FY2022 · AR
Rapid Phenotypic Antibiotic Susceptibility Testing
$203,215Ronald J Rieder · Biosense Technologies, Inc. · R43 · FY2016 · AI
The role of the collecting duct in defense of the lower urinary system in congenital and acquired uropathies
$203,187Jonathan M. Barasch · Columbia University Health Sciences · U54 · FY2018 · DK
Institutional Training Grant in Pediatric Infectious Disease
$203,163Coleen K. Cunningham · Duke University · T32 · FY2011 · HD
Enzyme-instructed nanoscale assemblies for killing multidrug resistant bacteria
$203,125Bing Xu · Brandeis University · R21 · FY2017 · AI
Host-microbe interaction in Drosophila gut
$203,125Y. Tony Ip · Univ Of Massachusetts Med Sch Worcester · R21 · FY2007 · DK
Dietary fiber to mitigate antibiotic-induced microbiome dysbiosis: a multi-omics approach
$203,125Peter Belenky · Brown University · R21 · FY2020 · AT
VTEU: Noninferiority Trial to Inform Treatment of Lower Respiratory Tract Infections (LRTI)
$203,024Hana El Sahly · Baylor College Of Medicine · N01 · FY2017 · AI
The interface between critical acid-base mediators and the renal bacterial defense
$203,014Andrew Lawrence Schwaderer · Indiana University Indianapolis · R01 · FY2017 · DK
Novel Anti-infective and Anti-thrombotic Micro-patterned Central Venous Catheter
$203,004Shravanthi Reddy · Sharklet Technologies, Inc. · R43 · FY2012 · HL
Inhalation Murine Model for B Anthacis and Y Pestis
$202,924Ordway Research Institute, Inc. · P01 · FY2005 · AI
TNF and caspase-8-mediated control of Legionella pneumophila infection
$202,917Sunny Shin · University Of Pennsylvania · R21 · FY2021 · AI
Indigenous Free Fatty Oleic acid Against MRSA Skin Infection
$202,876Chun-Ming Huang · University Of California, San Diego · R21 · FY2011 · AI
Institutional Training Grant in Pediatric Infectious Disease
$202,729Coleen K. Cunningham · Duke University · T32 · FY2015 · HD
Dealing with Antibiotic Resistance: Antisense Technology
$202,650Marcelo E Tolmasky · California State University Fullerton · R15 · FY2009 · AI
Precision characterization of antimicrobial resistance gene dynamics in bloodstream infection risk after hematopoietic stem cell transplantation
$202,619Tessa Andermann · Univ Of North Carolina Chapel Hill · K23 · FY2022 · AI
Precision characterization of antimicrobial resistance gene dynamics in bloodstream infection risk after hematopoietic stem cell transplantation
$202,619Tessa Andermann · Univ Of North Carolina Chapel Hill · K23 · FY2025 · AI
Precision characterization of antimicrobial resistance gene dynamics in bloodstream infection risk after hematopoietic stem cell transplantation
$202,619Tessa Andermann · Univ Of North Carolina Chapel Hill · K23 · FY2023 · AI
Precision characterization of antimicrobial resistance gene dynamics in bloodstream infection risk after hematopoietic stem cell transplantation
$202,619Tessa Andermann · Univ Of North Carolina Chapel Hill · K23 · FY2024 · AI
Precision characterization of antimicrobial resistance gene dynamics in bloodstream infection risk after hematopoietic stem cell transplantation
$202,619Tessa Andermann · Univ Of North Carolina Chapel Hill · K23 · FY2021 · AI
Synthesis and Mechanistic Studies of Peptide Antibiotics
$202,618Michael S Vannieuwenhze · Trustees Of Indiana University · R01 · FY2007 · AI